{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T04:23:24Z","timestamp":1782361404505,"version":"3.54.5"},"reference-count":54,"publisher":"MDPI AG","issue":"10","license":[{"start":{"date-parts":[[2024,5,7]],"date-time":"2024-05-07T00:00:00Z","timestamp":1715040000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Animals"],"abstract":"<jats:p>Canine melanoma is a malignant and aggressive neoplasm showing clinical, histological, and molecular features similar to the human counterpart. In human medicine, epidermal growth factor receptors (EGFRs) have already been suggested as prognostic markers and potential therapeutic targets in cutaneous melanoma. The aim of this study was to evaluate the expression of HER-2 and HER-3 in canine melanomas by immunohistochemistry and correlate their expression to the clinicopathological parameters of the examined tumors. Thirty-seven canine melanoma samples were recruited. Data regarding signalment and clinical parameters were also collected. The population was composed of 18 cutaneous, 16 oral\/mucosal, and three digital\/foot pad melanomas. Histopathological investigations were carried out to analyze histological type, ulceration, and mitotic count. On each sample, immunohistochemistry was performed using an anti-Melan-A or anti-Melanoma antigen, i.e., anti-HER-2 and anti-HER-3 antibodies. HER-2 and HER-3 positivity were classified using already established scoring criteria and a statistical analysis was carried out. The results highlighted that HER-2 expression was observed in 48.6% of the samples and HER-3 expression in 18.9%. The highest HER 2 score (3+) was recorded in 16.2% of the samples, while the coexpression of the two receptors was detected in 13.5% of the samples. A statistically significant association (p &lt; 0.05) was observed between the expression of HER-2 and HER-3 and the presence of ulceration in oromucosal tumors. This work confirms the expression of HER-2 and HER-3 in canine melanomas and suggests a putative association with negative prognostic parameters. Further studies are necessary to strengthen these data by increasing the samples size and combining pathological examinations with molecular biology in the investigation of EGFR family receptors.<\/jats:p>","DOI":"10.3390\/ani14101400","type":"journal-article","created":{"date-parts":[[2024,5,7]],"date-time":"2024-05-07T09:03:38Z","timestamp":1715072618000},"page":"1400","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["A Preliminary Evaluation of the Prognostic Role of HER-2 and HER-3 Immunohistochemical Expression in Canine Melanomas"],"prefix":"10.3390","volume":"14","author":[{"given":"Francesca","family":"Parisi","sequence":"first","affiliation":[{"name":"Dipartimento di Scienze Veterinarie, Universit\u00e0 di Pisa, Viale delle Piagge 2, 56124 Pisa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi","family":"Aurisicchio","sequence":"additional","affiliation":[{"name":"Evvivax Srl, Via Castel Romano 100, 00128 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arianna","family":"Pecorari","sequence":"additional","affiliation":[{"name":"Dipartimento di Scienze Veterinarie, Universit\u00e0 di Pisa, Viale delle Piagge 2, 56124 Pisa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Poli","sequence":"additional","affiliation":[{"name":"Dipartimento di Scienze Veterinarie, Universit\u00e0 di Pisa, Viale delle Piagge 2, 56124 Pisa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5661-1538","authenticated-orcid":false,"given":"Francesca","family":"Millanta","sequence":"additional","affiliation":[{"name":"Dipartimento di Scienze Veterinarie, Universit\u00e0 di Pisa, Viale delle Piagge 2, 56124 Pisa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,5,7]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0368-1742(55)80011-2","article-title":"Melanotic tumors of dogs","volume":"65","author":"Cotchin","year":"1999","journal-title":"J. Comp. Pathol. Ther."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"4582","DOI":"10.1016\/j.vaccine.2005.08.027","article-title":"Development of a xenogeneic DNA vaccine program for canine malignant melanoma at the Animal Medical Center","volume":"24","author":"Bergman","year":"2006","journal-title":"Vaccine"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1111\/pcmr.12170","article-title":"Naturally occurring melanomas in dogs as models for non-UV pathways of human melanomas","volume":"27","author":"Gillard","year":"2014","journal-title":"Pigment. Cell Melanoma Res."},{"key":"ref_4","unstructured":"Goldschmidt, M.H., and Shofer, F.S. (1992). Skin Tumors of the Dog and Cat, Pergamon Press Ltd."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1354\/vp.39-6-651","article-title":"A comparative review of melanocytic neoplasms","volume":"39","author":"Smith","year":"2002","journal-title":"Vet. Pathol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1002\/path.5505","article-title":"Spontaneously occurring melanoma in animals and their relevance to human melanoma","volume":"252","author":"Brenn","year":"2020","journal-title":"J. Pathol."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Rees, J.L. (2008). Melanoma: What are the gaps in our knowledge. PLoS Med., 5.","DOI":"10.1371\/journal.pmed.0050122"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1038\/jid.2008.423","article-title":"Increasing burden of melanoma in the United States","volume":"129","author":"Linos","year":"2009","journal-title":"J. Invest. Dermatol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1354\/vp.43-2-136","article-title":"The histologic and epidemiologic bases for prognostic considerations in canine melanocytic neoplasia","volume":"43","author":"Spangler","year":"2006","journal-title":"Vet. Pathol."},{"key":"ref_10","first-page":"66","article-title":"Melanocytic tumour classification and the pathway concept of melanoma pathogenesis","volume":"Volume 11","author":"Elder","year":"2018","journal-title":"WHO Classification of Skin Tumours"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1111\/j.1600-0560.2011.01673.x","article-title":"EGFR in melanoma: Clinical significance and potential therapeutic target","volume":"38","author":"Boone","year":"2011","journal-title":"J. Cutan. Pathol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/bs.acr.2020.04.001","article-title":"HER family in cancer progression: From discovery to 2020 and beyond","volume":"147","author":"Kumar","year":"2020","journal-title":"Adv. Cancer Res."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/j.ijrobp.2003.06.002","article-title":"Signal transduction and oncogenesis by ErbB\/HER receptors","volume":"58","author":"Marmor","year":"2004","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"5268","DOI":"10.1158\/1078-0432.CCR-05-1554","article-title":"The epidermal growth factor receptor pathway: A model for targeted therapy","volume":"12","author":"Scaltriti","year":"2006","journal-title":"Clin. Cancer Res."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1016\/S0959-8049(01)00231-3","article-title":"EGFR and cancer prognosis","volume":"37","author":"Nicholson","year":"2001","journal-title":"Eur. J. Cancer"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1038\/bjc.1997.283","article-title":"C-erbB-2 oncoprotein detected by automated quantitative immunocytochemistry in breast carcinomas correlates with patients\u2019 overall and disease-free survival","volume":"75","author":"Charpin","year":"1997","journal-title":"Br. J. Cancer"},{"key":"ref_17","first-page":"S53","article-title":"HER-2\/neu (c-erb-B2) gene and protein in breast cancer","volume":"112","author":"Ross","year":"1999","journal-title":"Am. J. Clin. Pathol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"5878","DOI":"10.1158\/0008-5472.CAN-08-0380","article-title":"A central role for HER3 in HER2-amplified breast cancer","volume":"68","author":"Crocker","year":"2008","journal-title":"Cancer Res."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1038\/sj.bjc.6604769","article-title":"Evaluation of the prognostic and predictive value of HER family mRNA expression in high-risk early breast cancer: A Hellenic Cooperative Oncology Group (HeCOG) study","volume":"99","author":"Koutras","year":"2008","journal-title":"Br. J. Cancer"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1002\/ijc.11273","article-title":"Prognostic value of ERBB family mRNA expression in breast carcinomas","volume":"106","author":"Onody","year":"2003","journal-title":"Int. J. Cancer"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/j.1365-2559.2004.01898.x","article-title":"Cyclooxygenase 2 (COX2) expression is associated with poor outcome in ER-negative, but not ER-positive, breast cancer","volume":"45","author":"Witton","year":"2004","journal-title":"Histopathology"},{"key":"ref_22","unstructured":"Goldschmidt, M.H., and Hendrick, M.J. (2008). Tumors in Domestic Animals, Iowa State Press."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Smedley, R.C., Sebastian, K., and Kiupel, M. (2022). Diagnosis and Prognosis of Canine Melanocytic Neoplasms. Vet. Sci., 9.","DOI":"10.3390\/vetsci9040175"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1111\/j.1440-1827.2011.02667.x","article-title":"Re-evaluation of melanin bleaching using warm diluted hydrogen peroxide for histopathological analysis","volume":"61","author":"Momose","year":"2011","journal-title":"Pathol. Int."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.tvjl.2010.08.012","article-title":"Expression of HER-2 and nuclear localization of HER-3 protein in canine mammary tumors: Histopathological and immunohistochemical study","volume":"189","author":"Kim","year":"2011","journal-title":"Vet. J."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Veloso, E.S., Gon\u00e7alves, I.N.N., Silveira, T.L., Oliveira, F.S., Vieira, D.S., Cassali, G.D., Del Puerto, H.L., and Ferreira, E. (2020). Diverse roles of epidermal growth factors receptors in oral and cutaneous canine melanomas. BMC Vet. Res., 16.","DOI":"10.1186\/s12917-020-2249-2"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1158\/0008-5472.338.65.1","article-title":"Novel prognostic value of nuclear epidermal growth factor receptor in breast cancer","volume":"65","author":"Lo","year":"2005","journal-title":"Cancer Res."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.ceb.2008.12.010","article-title":"ErbB receptors and signaling pathways in cancer","volume":"21","author":"Hynes","year":"2009","journal-title":"Curr. Opin. Cell Biol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"102436","DOI":"10.1016\/j.ctrv.2022.102436","article-title":"Beyond HER2: Targeting the ErbB receptor family in breast cancer","volume":"109","author":"Drago","year":"2022","journal-title":"Cancer Treat. Rev."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1111\/j.1365-2559.2007.02889.x","article-title":"Triple negative tumours: A critical review","volume":"52","author":"Tutt","year":"2008","journal-title":"Histopathology"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s10549-012-2289-9","article-title":"Role of epidermal growth factor receptor in breast cancer","volume":"136","author":"Masuda","year":"2012","journal-title":"Breast Cancer Res. Treat."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/j.juro.2010.04.077","article-title":"Her-2\/neu expression in prostate adenocarcinoma: A systematic review and meta-analysis","volume":"184","author":"Neto","year":"2010","journal-title":"J. Urol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1002\/cncr.20957","article-title":"Association of HER-2 overexpression with prognosis in nonsmall cell lung carcinoma: A metaanalysis","volume":"103","author":"Nakamura","year":"2005","journal-title":"Cancer"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"69060","DOI":"10.18632\/oncotarget.11264","article-title":"HER-2 inhibition in gastric and colorectal cancers: Tangible achievements, novel acquisitions and future perspectives","volume":"7","author":"Fanotto","year":"2016","journal-title":"Oncotarget"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1097\/00008390-200204000-00006","article-title":"Overexpression of HER-2 in thick melanoma","volume":"12","author":"Eliopoulos","year":"2002","journal-title":"Melanoma Res."},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Terragni, R., Casadei Gardini, A., Sabattini, S., Bettini, G., Amadori, D., Talamonti, C., Vignoli, M., Capelli, L., Saunders, J.H., and Ricci, M. (2014). EGFR, HER-2 and KRAS in canine gastric epithelial tumors: A potential human model?. PLoS ONE, 9, Erratum in PLoS ONE\u00a02015, 10, e0119048.","DOI":"10.1371\/journal.pone.0119048"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1111\/vco.12345","article-title":"Overexpression of HER-2 via immunohistochemistry in canine urinary bladder transitional cell carcinoma\u2014A marker of malignancy and possible therapeutic target","volume":"16","author":"Millanta","year":"2018","journal-title":"Vet. Comp. Oncol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1038\/s41598-021-04229-0","article-title":"Lapatinib as first-line treatment for muscle-invasive urothelial carcinoma in dogs","volume":"12","author":"Maeda","year":"2022","journal-title":"Sci. Rep."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1111\/rda.13903","article-title":"Expression of HER-2 and Ki-67 in granulosa cell tumor in bitches","volume":"56","author":"Consalter","year":"2021","journal-title":"Reprod. Domest. Anim."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1354\/vp.41-3-291","article-title":"Overexpression of the erbB-2 proto-oncogene in canine osteosarcoma cell lines and tumors","volume":"41","author":"Flint","year":"2004","journal-title":"Vet. Pathol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1292\/jvms.20-0026","article-title":"Overexpression of human epidermal growth factor receptor 2 in canine primary lung cancer","volume":"82","author":"Yoshimoto","year":"2020","journal-title":"J. Vet. Med. Sci."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1292\/jvms.19-0019","article-title":"Detection of human epidermal growth factor receptor 2 overexpression in canine anal sac gland carcinoma","volume":"81","author":"Yoshimoto","year":"2019","journal-title":"J. Vet. Med. Sci."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/j.1476-5810.2005.00063.x","article-title":"Immunohistochemical detection of HER-2\/neu expression in spontaneous feline mammary tumours","volume":"3","author":"Winston","year":"2005","journal-title":"Vet. Comp. Oncol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1354\/vp.42-1-30","article-title":"Overexpression of HER-2 in feline invasive mammary carcinomas: An immunohistochemical survey and evaluation of its prognostic potential","volume":"42","author":"Millanta","year":"2005","journal-title":"Vet. Pathol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/rda.12642","article-title":"Changes in c-erbB-2 Immunoexpression in Feline Endometrial Adenocarcinomas","volume":"51","author":"Saraiva","year":"2016","journal-title":"Reprod. Domest. Anim."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1177\/0300985820988147","article-title":"HER2 Overexpression and Amplification in Feline Pulmonary Carcinoma","volume":"58","author":"Muscatello","year":"2021","journal-title":"Vet. Pathol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1002\/ijc.22928","article-title":"EGFR gene copy number alterations in primary cutaneous malignant melanomas are associated with poor prognosis","volume":"121","author":"Ecsedi","year":"2007","journal-title":"Int. J. Cancer"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1477-3163-2-8","article-title":"Immunohistochemical determination of HER-2\/neu overexpression in malignant melanoma reveals no prognostic value, while c-kit (CD117) overexpression exhibits potential therapeutic implications","volume":"2","author":"Potti","year":"2003","journal-title":"J. Carcinog."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1097\/01.cmr.0000130874.33504.2f","article-title":"Her2\/ neu is not a commonly expressed therapeutic target in melanoma\u2014A large cohort tissue microarray study","volume":"14","author":"Kluger","year":"2004","journal-title":"Melanoma Res."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"421","DOI":"10.7314\/APJCP.2015.16.2.421","article-title":"Negative HER2\/neu amplification using immunohistochemistry and chromogenic in situ hybridization techniques in skin melanoma cases","volume":"16","author":"Shayanfar","year":"2015","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Meuten, D.J. (2016). Tumors in Domestic Animals, John Wiley & Sons. [5th ed.].","DOI":"10.1002\/9781119181200"},{"key":"ref_52","doi-asserted-by":"crossref","unstructured":"Pellin, M.A. (2022). The Use of Oncept Melanoma Vaccine in Veterinary Patients: A Review of the Literature. Vet. Sci., 9.","DOI":"10.3390\/vetsci9110597"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"5188","DOI":"10.1158\/1078-0432.CCR-08-0186","article-title":"HER3 is a determinant for poor prognosis in melanoma","volume":"14","author":"Reschke","year":"2008","journal-title":"Clin. Cancer Res."},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"Giuliano, A. (2021). Companion Animal Model in Translational Oncology; Feline Oral Squamous Cell Carcinoma and Canine Oral Melanoma. Biology, 11.","DOI":"10.3390\/biology11010054"}],"container-title":["Animals"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-2615\/14\/10\/1400\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T14:41:04Z","timestamp":1760107264000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-2615\/14\/10\/1400"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,7]]},"references-count":54,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2024,5]]}},"alternative-id":["ani14101400"],"URL":"https:\/\/doi.org\/10.3390\/ani14101400","relation":{},"ISSN":["2076-2615"],"issn-type":[{"value":"2076-2615","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,7]]}}}